Medical technology company Olympus has introduced its new ESG-410 electrosurgical generator to treat enlarged prostate and bladder cancer.

The electrosurgical generator offers a range of band electrodes, vaporisation buttons, needles and resection loops, which help in efficiently treating non-muscle-invasive bladder cancer and benign prostatic hyperplasia or enlarged prostate.

The ESG-410 features larger capacitors compared to the company’s previous model, the ESG-400, enabling improved plasma stability during ignition.

The generator can offer rapid ignition and enhanced plasma stability while avoiding tissue contact with large, medium and band loops and oval buttons, compared to the previous version.

Furthermore, it also has a larger 8.4″ LCD touch screen than the ESG-400 and wireless foot pedals. Olympus is also offering wired options for the generator.

Using its accessories and ancillary equipment, the generator will support cutting and coagulating tissue in open, laparoscopic and endoscopic surgery. It must be used by a qualified physician in a suitable medical environment.

According to Olympus, incorrect use of the electrosurgical generator or incompatible use of equipment may result in the generation of excessive or incorrect high-frequency energy, potentially leading to thermal or other injuries for both the patient and the operator.

In December last year, Olympus reached a definitive agreement to acquire UK-based cloud-AI endoscopy start-up Odin Vision.

Odin Vision offers a portfolio of computer-aided diagnostic solutions, as well as a deep innovation pipeline of cloud-enabled applications.